Skip to content

Observational Study to Evaluate the STALIF® C FLX, STALIF® M FLX, STALIF® L FLX Cages and FORTOS-C®

Sponsor-initiated, Retrospective, Monocentric, Non-interventional Clinical Observational Study to Evaluate the STALIF® C FLX, STALIF® M FLX, STALIF® L FLX Cages and FORTOS-C®

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06876311
Enrollment
100
Registered
2025-03-14
Start date
2025-03-04
Completion date
2025-05-30
Last updated
2025-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Cervical Disc Disease, Degenerative Lumbar Diseases

Brief summary

Post-operative clinical outcome data on the devices used to treat spinal diseases are collected and evaluated in order to analyze the safety and performance of the implants used.

Interventions

Standard Anterior Cervical Interbody Fusion with Stand-alone Cervical Cages

Standard Anterior Lumbar Interbody Fusion with Stand-Alone Lumbar Cages

Standard Lateral Lumbar Interbody Fusion with Stand-alone Lumbar cage

Sponsors

Silony Medical GmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Indications according to IFU Surgical implantation of STALIF® C or M FLX device for 1 or 2 levels between: * STALIF® C FLX: C2-T1 (cervical) * STALIF® M FLX: L2-S1 (lumbar) * STALIF® L FLX: L2-L5 (lumbar) Surgical implantation of FORTOS-C® for the fusion of up to 3 levels between: * FORTOS-C®: C2 - T1 (cervical) * Age: ≥ 21 years * For the evaluation of the questionnaires (NDI or ODI, VAS neck and VAS arm or VAS leg and VAS back), only patients with the questionnaire available at the time of admission (pre-op) and at least at 12-months FU will be included

Exclusion criteria

* Relative and absolute contraindications according to IFU

Design outcomes

Primary

MeasureTime frameDescription
Neck Disability IndexBaseline, 3 months postoperative, 6 months postoperative, 12 months postoperative, 24 months postoperativeThe Neck Disability Index (NDI) has 10 items that cover various aspects of daily functioning, such as pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation. Scoring: Each question contains six answer choices, scored from 0 (no disability) to 5 (complete disability). All section scores are then totaled. Scoring is reported on a 0-50 scale, 0 being the best possible score and 50 being the worst. Alternately, the score can be reported from 0-100. The score is often reported as a percentage (0-100%).
Oswestry Disability IndexBaseline, 3 months postoperative, 6 months postoperative, 12 months postoperative, 24 months postoperativeThe Oswestry Disability Index (ODI) is used to measure the extent of pain-related functional limitations in people with low back pain. The questionnaire provides the user with information about the general functional ability of a patient with low back pain in everyday life. Six response options are available for the following items: pain intensity, self-care (washing, dressing), lifting, locomotion, sitting or standing, sleeping, sex life, social life and travel/transportation. The first answer option (score 0) means that there are no pain-related restrictions, while the sixth answer option (score 5) indicates the greatest perceived restriction of an activity due to pain.

Secondary

MeasureTime frameDescription
Visual Analogue ScaleBaseline, 3 months postoperative, 6 months postoperative, 12 months postoperative, 24 months postoperativeThe Visual Analogue Scale (VAS) is usually quantified from 0 to 10, where 0 means 'no pain' and 10 means 'strongest pain imaginable'.
Radiological assessmentBaseline, 3 months postoperative, 6 months postoperative, 12 months postoperative, 24 months postoperative* Implant migration/ Subsidence/ Screw Back-out * Bone Fusion at latest follow-up
ComplicationsBaseline, 3 months postoperative, 6 months postoperative, 12 months postoperative, 24 months postoperativeIntraoperative and postoperative complications, revisions, and (serious) adverse events

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026